Startups to unveil cutting-edge point-of-care technologies at Boston medtech event
Innovations to assist patients with heart, blood, lung and sleep disorders
2023-06-02
(Press-News.org) June 2, 2023
Contact:
Emily Gowdey-Backus, 978-934-3369 or Emily_GowdeyBackus@uml.edu
Nancy Cicco, 978-934-4944 or Nancy_Cicco@uml.edu
Startups to unveil cutting-edge point-of-care technologies at Boston medtech event
Medtech and life sciences entrepreneurs and investors forging the future of health care will come together Tuesday, June 6, to showcase pioneering technologies and grow the region’s medtech ecosystem.
The 2023 Point of Care Showcase and Pitch Event will be a free, in-person program beginning at 2 p.m. at Mintz, 1 Financial Center, 40th Floor, Boston, to introduce innovations to improve the well-being of patients with heart, blood, lung and sleep disorders.
The event will be hosted by the UMass Center for Advancing Point of Care Technologies (CAPCaT), a business incubator funded by the National Institutes of Health. The center is housed within the Massachusetts Medical Development Center (M2D2), a joint venture of UMass Lowell and Worcester-based UMass Chan Medical School. M2D2 assists entrepreneurs with all aspects of moving new products and technologies from the drawing board to the marketplace.
“This year, our keynote session will feature Dr. Maria Berkman, head of medtech for Broadview Ventures, and V. Kadir Kadhiresan, vice president for venture investments at Johnson & Johnson, in what we expect will be a rousing fireside chat on entrepreneurship in biotech,” said UMass Lowell’s Bryan Buchholz, professor emeritus of biomedical engineering. Buchholz co-directs CAPCaT alongside David McManus, MD, the Richard M. Haidack Professor and chair and professor of medicine of the Department of Medicine at UMass Chan Medical School, where he is the founding director of the program in digital medicine.
Entrepreneurs from five companies developing point-of-care innovations will pitch their inventions before a panel of experts. These startups and products, which received funding from CAPCaT last year, include:
VoluMetrix – A new method of noninvasive blood-flow analysis for heart failure patients
VPG Medical – A suite of medical-grade, video-based, heath-monitoring software
for mobile devices and personal computers
Brainstem Biometrics – A specific and non-invasive way to measure basic brainstem function
InfraredRx – Innovations to manage peripheral artery disease
General Prognostics – Technology to remotely monitor blood biomarkers
“The CAPCaT collaboration between UMass Chan and UMass Lowell has supported more than 30 small tech companies in their journey from idea to product. By helping these companies to conduct meaningful clinical trials and providing access to patient perspectives, clinician feedback, and entrepreneur communities, we have saved a few wonderful ideas from stalling and have shortened the time it takes others to get their product commercialized,” McManus said. “We are very excited to be holding our fourth annual 2023 Point of Care Pitch Event and Showcase featuring five CAPCaT point-of-care testing (PoCT) startups. Join us and open the doors to big company/little company strategic partnerships and grant funding opportunities.”
Creating a dynamic networking opportunity for attendees, the event’s venue is within walking distance of the Boston Convention Center, which will welcome hundreds of other entrepreneurs, researchers and funders working in the medtech and sustainability justice sectors to the 2023 BIO International Convention, from Monday, June 5 through Thursday, June 8.
Since its inception in 2007, M2D2 has vetted more than 250 medical device and biotech ventures and supported more than 100 startups. In total, M2D2 resident companies have secured more than $150 million in external funding for their innovations.
Individuals interested in attending the CAPCaT event should register here.
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-06-02
A team of researchers from EPFL have found a way to use the phenomenon of strong gravitational lensing to determine with precision – about 3 times more precise than any other technique – the mass of a galaxy containing a quasar, as well as their evolution in cosmic time. Knowing the mass of quasar host galaxies provides insight into the evolution of galaxies in the early universe, for building scenarios of galaxy formation and black hole development. The results are published in Nature ...
2023-06-02
BOSTON – Various medications can be prescribed to lower blood sugar levels in individuals at high risk for developing type 2 diabetes, but it’s often unclear which patients will benefit most from which drugs.
In a study published in Diabetologia, investigators at Massachusetts General Hospital (MGH), founding member of Mass General Brigham (MGB), identified genetic variants associated with response to two such drugs: metformin and glipizide. The findings may help personalize ...
2023-06-02
Twenty-five teachers from Redlands Unified School District in southern California recently completed training in integrating computer science into math education through a joint program offered by the University of California, Davis, and UC Riverside Extension. The Joint Computer Science Supplementary Teaching Credential Authorization Program has helped Redlands address gaps in student opportunity and achievement, and teachers’ skills.
“Improving math instruction for student success is the most challenging task in education. Redlands partnered with UC Davis to make math instruction with ...
2023-06-02
The Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, classify objective tumor response into one of four categories (complete or partial response, or stable or progressive disease) based on the percent of change in the sum of the longest diameters of a set of target lesions.
An analysis of data from the SWOG S1609 trial conducted by the NCI-funded National Clinical Trials Network (NCTN) finds that in patients treated with immune checkpoint inhibitors, survival times correlate linearly with that change, rather than exhibiting threshold effects ...
2023-06-02
A new study from researchers in the Khurana lab at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, in close collaboration with researchers from the Ritz lab at UCLA and the Rubin lab at Harvard University, identified pesticides that could be relevant to the development of Parkinson’s disease. The study was led by Richard Krolewski, MD, PhD, a neurologist in the Brigham’s Division of Movement Disorders and Ann Romney Center for Neurologic Diseases, and Kimberly ...
2023-06-02
Among patients with extensive stage small-cell lung cancer (SCLC) that is positive for expression of the Schlafen-11 gene (SLFN11), those who received maintenance atezolizumab immunotherapy plus the PARP inhibitor talazoparib had significantly longer progression-free survival (PFS) times than those who received atezolizumab alone (median PFS 4.2 months versus 2.8 months).
These results from the phase II S1929 trial conducted by the SWOG Cancer Research Network, a clinical trials group funded by the National Cancer Institute (NCI), will be reported ...
2023-06-02
Oncology specialists from around the globe will gather for the American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest cancer therapies, technologies, research and education.
The theme this year is Partnering With Patients: The Cornerstone of Cancer Care and Research. More than 30,000 people are expected to attend the meeting taking place in Chicago and online June 2-6, 2023.
“As the world’s leading clinical cancer meeting, ASCO is an important event for oncology professionals to share information on the latest ...
2023-06-02
Multiple sclerosis has traditionally been considered a condition that predominantly affects white people of European ancestry. However, a new analysis conducted by a North American team led by University of Maryland School of Medicine (UMSOM) researchers suggests that the debilitating neurological condition is more prevalent in Black Americans than once thought. It is also far more prevalent in Northern regions of the country including New England, the Dakotas, and the Pacific Northwest.
Findings from the new study were recently published in the journal JAMA Neurology.
“We found a much higher prevalence of multiple sclerosis in Black Americans than previously ...
2023-06-02
New results from a study led by USC researchers at Children’s Hospital Los Angeles show that a sensory adapted dental clinic environment creates less distressing oral care experiences for autistic children. The open-access article is available today in JAMA Network Open.
“We’ve shown that the combination of curated visual, auditory and tactile adaptations — all of which are easily implemented, relatively inexpensive and don’t require training to safely use — led to statistically significant decreases in autistic children’s behavioral ...
2023-06-02
Key takeaways:
A UCLA study shows that a the outset of the COVID-19 pandemic, social interactions, both virtual and in person, declined significantly for married couples.
The decline was found to be greater and more long-lasting for Black and Latino couples and lower-income couples than for white couples and wealthier couples.
The researchers suggest exploring new ways of protecting public health during crises that also help more vulnerable populations sustain meaningful relationships.
Following the lockdowns and restrictions on public gatherings in the early days of COVID-19, the social networks of white, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Startups to unveil cutting-edge point-of-care technologies at Boston medtech event
Innovations to assist patients with heart, blood, lung and sleep disorders
